Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery

NCT00887861 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Seizures
Epilepsy

Interventions

DRUG: Investigational new drug, company code: BGG492
DRUG: Placebo

Sponsor

Novartis